OCT 06, 2020 11:26 PM PDT

Drug For A Severe E. Coli Infection

WRITTEN BY: Nouran Amin

Escherichia coli, known as E. coli, is a popular bacterium associated with food poisoning and depending on the strain can cause enterohemorrhagic E. coli (EHEC).

EHEC is a severe infection that affects the brain and kidneys via the release of Shiga toxins. To combat the infection, researchers discovered a new molecular pathway that can be the basis of a therapeutic. The study comes especially critical as there are no commercially available treatments for the infection.

"Antibiotic treatment of these infections is generally not recommended because antibiotics stimulate production of the Shiga toxin, leading to an increased risk of kidney failure, neurological damage, and death," says Dr. Jai Tree, the study's senior author.

Learn more about E. coli:

Findings were published this week in the Proceedings of the National Academy of Sciences.

"The new pathway that we have found reduces toxin production and is not expected to be stimulated by antibiotic treatment. So, our results identify a potential new target for the development of drugs that can suppress Shiga toxin production during EHEC infection.

"It's still early days, however, and we need to conduct a lot more research to understand if our findings apply to a broad range of clinical EHEC isolates and to both types of Shiga toxins produced by human EHEC isolates."

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
NOV 12, 2021
Cannabis Sciences
Battle of the Cannabinoids: Which Cannabis Compound Could Most Effectively Treat IBD?
NOV 12, 2021
Battle of the Cannabinoids: Which Cannabis Compound Could Most Effectively Treat IBD?
With 3 million people from the U.S. reporting clinical cases in 2015 – accompanied by an increased projected incid ...
NOV 18, 2021
Cannabis Sciences
Is Cannabis Useful for Symptoms of Endometriosis?
NOV 18, 2021
Is Cannabis Useful for Symptoms of Endometriosis?
Endometriosis is a common gynecologic disorder impacting up to 10% of women of reproductive age in the United ...
DEC 04, 2021
Cannabis Sciences
Modulating the CBD/Apelinergic System Interaction as a COVID-19 Treatment?
DEC 04, 2021
Modulating the CBD/Apelinergic System Interaction as a COVID-19 Treatment?
Although CBD has long been implicated as an anti-inflammatory agent, it is only within the past few decades that it has ...
DEC 07, 2021
Microbiology
Gut Microbes Could Help Protect Us From Viral Infection, Including COVID-19
DEC 07, 2021
Gut Microbes Could Help Protect Us From Viral Infection, Including COVID-19
The human microbiome is closely connected to our immune system. Our bodies have to be able to keep the bacterial populat ...
JAN 11, 2022
Cannabis Sciences
Cannabis Varieties Used in Research Vary Significantly from Consumer Varieties
JAN 11, 2022
Cannabis Varieties Used in Research Vary Significantly from Consumer Varieties
Until just days ago, the University of Mississippi (UM) monopolized the cannabis research industry. Through a contract e ...
JAN 11, 2022
Drug Discovery & Development
The FDA grants approval for a new insomnia drug to improve sleep in adults
JAN 11, 2022
The FDA grants approval for a new insomnia drug to improve sleep in adults
The Swiss biotech company Idorsia announced this week that it has received approval from the United States Foo ...
Loading Comments...